Anna S. ROBEVA

37 papers receiving 2.5k citations

Anna S. ROBEVA's Hit Papers

Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer 2020 · 732 citations
7320+2+4Years since publication200400600

Peers

Anna S. ROBEVA
Comparison fields: 5 of 99
  • Physiology 742
  • Developmental Neuroscience 180
  • Cellular and Molecular Neuroscience 686
  • Pulmonary and Respiratory Medicine 615
  • Oncology 403
Replace Alfredo Rodríguez Antigüedad with:
Alfredo Rodríguez Antigüedad Spain
Felipe Ortega Spain
Raymond P. Rothstein United States
Bernd Kinzel Switzerland
Yoshiko Maeda United States
Alwin G. Schuller United States
Cécile Delarasse France
Arnold Munnich France
Alessandro Fatatis United States
Rainer Maier Switzerland
Anna S. ROBEVA relative to Alfredo Rodríguez Antigüedad Spain Alfredo Rodríguez Antigüedad's profile →
Citations per field
00.5×5×10.3×
Alfredo Rodríguez Antigüedad · 1×
Citations per year

Countries citing papers authored by Anna S. ROBEVA

Since Specialization
Citations

This map shows the geographic impact of Anna S. ROBEVA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna S. ROBEVA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna S. ROBEVA more than expected).

Fields of papers citing papers by Anna S. ROBEVA

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna S. ROBEVA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna S. ROBEVA. The network helps show where Anna S. ROBEVA may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna S. ROBEVA, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna S. ROBEVA Line = papers co-authored together Anna S. ROBEVA links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer
Hit paper breakdown →
2020732
2 2003351
3 1998349
4 1993187
5 2001145
6 1999112
7 2007105
8 199482
9 199676
10 199668
11 200251
12 199249
13 202440
14 199935
15 201433
16 201829
17
Synthetic and endogenous inhibitors of snake venom metalloproteinases.
199127
18 200826
19 199318
20 199817

About Anna S. ROBEVA

Anna S. ROBEVA is a scholar working on Physiology, Cellular and Molecular Neuroscience, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 37 papers that have together received 2.6k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (14 papers), Adenosine and Purinergic Signaling (11 papers), Lung Cancer Treatments and Mutations (10 papers), Neuropeptides and Animal Physiology (6 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Physiology (742 citations), Developmental Neuroscience (180 citations), Cellular and Molecular Neuroscience (686 citations), Pulmonary and Respiratory Medicine (615 citations) and Oncology (403 citations). Anna S. ROBEVA has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Joel M Linden, Diane L. Rosin, Patrice G. Guyenet, Heidi E. Taylor, Amy L. Tucker, Rüdiger Vallon, Xiaowei Jin, Thomas Oertle, Christine E. Bandtlow and Lisa Schnell. Their work appears in journals such as Annals of Oncology, Molecular Pharmacology, The Journal of Comparative Neurology, Biochemical Journal and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact